Menu

NA Tender by Jawaharlal Nehru Port Trust (GEM/2025/B/6126597)

11602973,11602991,11603025,11603048,11603100,11603115,11603138,11603164,11603191,11603210,11603226,

Goods
Qty:11.7L
NA Tender by Jawaharlal Nehru Port Trust (GEM/2025/B/6126597)

Tender Timeline

Tender Issue
April 9, 2025 at 11:56 AM

The tender titled "163 BRANDED MEDICINES" and identified by reference number GEM/2025/B/6126597 is issued by the Ministry of Ports, Shipping and Waterways. This tender is aimed at procuring a substantial quantity of branded medicines, aligning with the national health objectives. The overall scope encompasses the sourcing, supply, and distribution of branded medicines, ensuring adherence to quality standards and timely delivery.

Scope of Work and Objectives

The main goal of this tender is to solicit bids for the procurement of approximately 1,172,523 units of various branded medicines categorized under several classifications. The successful bidders will be responsible for delivering these medicines to designated locations specified in the tender documents. The essential objective is to ensure the availability of high-quality medications to support public health initiatives efficiently and effectively.

Eligibility Criteria

To participate in this tender, bidders must meet specific eligibility requirements which generally include being legally registered entities, compliant with applicable laws, and possessing the necessary licenses to operate within the pharmaceutical field. Bidders should also have a demonstrated history of supplying similar products, showcasing their capability to meet the tender's extensive demands.

Technical Requirements

Participants must satisfy various technical specifications, including quality standards set forth by regulatory bodies. Bidders are expected to provide documentation that validates compliance with such standards, ensuring the medicines meet safety and efficacy benchmarks. This includes submitting certifications from recognized quality assurance organizations.

Financial Requirements

Bidders must be equipped to provide financial guarantees, namely an Earnest Money Deposit (EMD), which is a standard practice to ensure the seriousness of the bids. The details regarding the EMD, including the amount and submission process, are specified in the tender documentation, ensuring transparent engagement in the bidding process.

Document Submission Details

All submissions must adhere to the formats and guidelines specified in the tender documents. Bidders will need to submit mandatory documents including, but not limited to, business registration certificates, financial statements, quality certifications, and proposals, through the designated submission channels outlined by the Ministry.

Special Provisions

This tender is encouraged to support Micro, Small, and Medium Enterprises (MSEs), offering them a competitive edge through specific provisions aimed at promoting local entrepreneurship. Additionally, provisions for startups are included, thus fostering innovation in the supply of essential healthcare products.

Evaluation Process

The evaluation of submissions will be conducted based on predefined criteria emphasizing quality, price competitiveness, and the bidder's ability to meet delivery timelines. The Ministry reserves the right to further seek clarification from bidders, facilitating a thorough assessment of the proposals.

Delivery Locations

Successful bidders will be required to deliver the medicines to various predetermined locations as specified in the tender. This might include public health facilities across the country, aligning with the Ministry’s commitment to enhancing healthcare accessibility.

Contact Information

For any queries or clarifications related to the tender, bidders can refer directly to contact details provided within the official tender documentation (specific details may not be available for public sharing).

In summary, the "163 BRANDED MEDICINES" tender represents a significant opportunity for entities within the pharmaceutical sector, fostering growth and ensuring the procurement of vital healthcare products within the Indian public health framework.

General Information

Item Category
11602973 , 11602991 , 11603025 , 11603048 , 11603100 , 11603115 , 11603138 , 11603164 , 11603191 , 11603210 , 11603226 , 11603277 , 11603328 , 11603332 , 11603360 , 11603373 , 11603377 , 11603436 , 11603482 , 11603503 , 11603509 , 11603518 , 11603524 , 11603542 , 11603495 , 11603628 , 11603296 , 11603686 , 11603693 , 11603697 , 11603700 , 11603713 , 11603721 , 11603739 , 11603752 , 11603755 , 11603731 , 11603763 , 11600146 , 11600152 , 11600242 , 11600367 , 11600073 , 11605106 , 11600269 , 11600193 , 11600262 , 11600211 , 11600390 , 11601315 , 11605110 , 11600766 , 11600778 , 11600932 , 11600934 , 11600795 , 11602141 , 11601306 , 11601427 , 11601399 , 11601438 , 11601475 , 11605131 , 11601394 , 11601584 , 11601587 , 11601599 , 11601962 , 11601852 , 11601934 , 11602007 , 11602824 , 11602758 , 11602841 , 11602774 , 11602844 , 11602538 , 11602515 , 11602584 , 11601991 , 11601913 , 11600401 , 11602110 , 11602124 , 11602208 , 11602226 , 11605046 , 11605049 , 11602205 , 11602231 , 11602441 , 11602370 , 11602393 , 11602926 , 11602940 , 11602642 , 11602678 , 11601164 , 11601779 , 11601816 , 11602603 , 11602575 , 11602617 , 11605163 , 11602597 , 11603349 , 11603302 , 11603347 , 11603345 , 11605040 , 11605925 , 11606025 , 11605961 , 11606216 , 11606230 , 11606235 , 11602135 , 11606238 , 11601073 , 11606102 , 11606001 , 11606004 , 11605984 , 11605995 , 11606105 , 11606268 , 11606298 , 11606303 , 11606306 , 11605671 , 11605653 , 11606354 , 11606341 , 11606335 , 11606351 , 11606345 , 11606386 , 11600457 , 11602835 , 11606429 , 11606447 , 11606443 , 11602034 , 11603357 , 11603358 , 11603359 , 11606458 , 11606462 , 11606468 , 11606472 , 11606475 , 11606487 , 11606498 , 11606510 , 11606485 , 11606503 , 11606451 , 11600372 , 11602961 , 11606518 , 11606520 , 11606533 , 11606535
Department Name
City

Financial Information

Bid Offer Validity
90 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7724759.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Frequently Asked Questions

The eligibility requirements include being a registered entity with relevant licenses in the pharmaceutical domain. Bidders must demonstrate experience in supplying branded medicines, providing documentation that verifies compliance with regulatory standards. It’s crucial for bidders to ascertain their capacity to deliver the quantities specified in the tender and to meet quality benchmarks established by health authorities.

To participate successfully, bidders are required to submit a range of documents such as business registration certificates, financial statements from recent fiscal periods, quality assurance certifications, and any relevant licenses. Ensuring that all documentation aligns with the technical specifications requested will enhance the likelihood of bid acceptance.

The Earnest Money Deposit (EMD) is a monetary guarantee that bidders must submit alongside their tender submission. Details regarding the EMD amount, submission format, and any applicable conditions are outlined in the tender documents. This deposit assures the Ministry of the bidder’s commitment and is typically refundable if the bid is unsuccessful.

Bidders are expected to follow designated submission methods as specified in the tender guidelines. This may include online submission through a designated portal or physical submissions at a specified address. It is essential to adhere to the outlined protocols to ensure that all documentation is received before the submission deadline.

Yes, participation in this tender requires strict adherence to outlined quality standards. Bidders must present documentation that attests to compliance with relevant health and safety regulations, showcasing that their products meet the necessary testing criteria. Transparency in providing quality assurance documentation is critical to the evaluation process.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders